Physician profile
Todd C Johnson
NPI 1205857901
$370.16
in general payments reported to CMS, 2019-2025
12 companies · $84.56 in 2025
The $84.56 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $106 · 2020: $74.52 · 2021: $11.84 · 2022: $39.97 · 2023: $53.19 · 2025: $84.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $137.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $79.33 | 2019-2025 | Proclaim |
| Abbvie INC. | $65.03 | 2021-2023 | |
| Tersera Therapeutics LLC | $47.37 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $33.13 | 2025 | Exparel |
| Pfizer INC. | $25.97 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $22.04 | 2019 | |
| Lundbeck LLC | $21.01 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $19.21 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $17.87 | 2025 | Ajovy |
| Baudax Bio INC. | $15.57 | 2020 | |
| Boston Scientific Corporation | $12.74 | 2020 | |
| Lilly USA, LLC | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.